Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Mysthera Therapeutics AG

Headquarters: Basel, Switzerland
Year Founded: 2023
Status: Private
BioCentury | Oct 30, 2023
Emerging Company Profile

Mysthera: restoring immune balance via PIM kinases

Basel-based company aims to dial down autoimmunity without shutting off helpful immune responses with $3.5M from Forty51
BioCentury | Aug 22, 2023
Finance

Aug. 22 Quick Takes: Forty51-backed Mysthera launches to development autoimmune therapies

Plus: FDA lifts hold on Fulcrum’s trial and more, panel to discuss Geron’s imetelstat
Items per page:
1 - 2 of 2
Help Center
Username
Request a Demo
Request Training
Ask a Question